Catheter Precision, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Catheter Precision, Inc. (VTAK) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$25.98 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2023-03-28
- Catheter Precision, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2022-09-30 was -$4.36.
- Catheter Precision, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2022-06-30 was -$0.26.
- Catheter Precision, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2021-09-30 was -$57.64.
- Catheter Precision, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2021-06-30 was -$1.15.
- Catheter Precision, Inc. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$25.98.
- Catheter Precision, Inc. income (loss) from continuing operations, per diluted share for fiscal 2021 was -$269.91.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$25.98 10-K · filed 2023-03-28 | |||
| 2022-09-30 | -$4.36 10-Q · filed 2022-11-14 | -$28.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$0.26 10-Q · filed 2022-08-16 | -$0.53 10-Q · filed 2022-08-16 | ||
| 2021-12-31 | -$269.91 10-K · filed 2023-03-28 | |||
| 2021-09-30 | -$57.64 10-Q · filed 2022-11-14 | -$210.82 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$1.15 10-Q · filed 2022-08-16 | -$3.31 10-Q · filed 2022-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |